Literature DB >> 3455168

Inhibition by citrate of spontaneous precipitation of calcium oxalate in vitro.

M J Nicar1, K Hill, C Y Pak.   

Abstract

Effect of citrate on the spontaneous precipitation of calcium oxalate was examined in synthetic media. Citrate significantly increased the formation product of calcium oxalate. This "direct" measure of inhibitor activity, representing activity product at the point of nucleation, rose by 76% by the addition of citrate sufficient to provide trivalent citrate concentration of 1.49 mM. Moreover, citrate inhibited calcium oxalate crystallization by complexing calcium and lowering calcium oxalate saturation. This "indirect" measure of inhibitor activity was assessed from the concentration product of calcium oxalate at the point of nucleation, since this measure should provide a reflection of both ion pair formation and direct inhibitor activity of citrate. The concentration product exceeded the formation product at all ionic (trivalent) citrate concentrations, particularly at high ionic citrate levels. At the ionic citrate concentration of 1.49 mM, the rise in the concentration product was 373%, which was nearly fivefold that observed for the formation product. The presence of ferric or aluminum cations at a physiologic concentration of 2 mg/l did not modify the increase in formation product produced by citrate. Thus, citrate inhibits calcium oxalate crystallization, largely by complexing citrate, but also by directly affecting nucleation. Presence of ferric or aluminum cations at a physiological concentration does not modify the inhibitor action of citrate.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3455168     DOI: 10.1002/jbmr.5650020308

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  15 in total

1.  Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.

Authors:  Shameez Allie-Hamdulay; Allen L Rodgers
Journal:  Urol Res       Date:  2005-05-04

Review 2.  Kidney stones: an update on current pharmacological management and future directions.

Authors:  Hongshi Xu; Anna L Zisman; Fredric L Coe; Elaine M Worcester
Journal:  Expert Opin Pharmacother       Date:  2013-03       Impact factor: 3.889

3.  Supersaturation of body fluids, plasma and urine, with respect to biological hydroxyapatite.

Authors:  Otakar Söhnel; Felix Grases
Journal:  Urol Res       Date:  2011-05-14

4.  A study of recurrent stone formers with special reference to renal tubular acidosis.

Authors:  P P Singh; A K Pendse; A Ahmed; D V Ramavataram; S K Rajpurohit
Journal:  Urol Res       Date:  1995

5.  Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium citrate administered over the short-, medium- and long-term medication of male stone patients.

Authors:  P O Schwille; U Herrmann; C Wolf; I Berger; R Meister
Journal:  Urol Res       Date:  1992

6.  Mechanism of urinary calcium regulation by urinary magnesium and pH.

Authors:  Olivier Bonny; Adam Rubin; Chou-Long Huang; William H Frawley; Charles Y C Pak; Orson W Moe
Journal:  J Am Soc Nephrol       Date:  2008-04-30       Impact factor: 10.121

7.  Hypocitraturia: pathophysiology and medical management.

Authors:  Jack M Zuckerman; Dean G Assimos
Journal:  Rev Urol       Date:  2009

8.  Metabolic assessment in pure struvite stones formers: is it necessary?

Authors:  Alexandre Danilovic; Thiago Augusto Cunha Ferreira; Samirah Abreu Gomes; Isabela Akemi Wei; Fabio Carvalho Vicentini; Fabio Cesar Miranda Torricelli; Giovanni Scala Marchini; Eduardo Mazzucchi; Miguel Srougi; William Carlos Nahas
Journal:  J Bras Nefrol       Date:  2021 Apr-Jun

Review 9.  Urolithiasis in children: medical approach.

Authors:  Lawrence Copelovitch
Journal:  Pediatr Clin North Am       Date:  2012-06-15       Impact factor: 3.278

10.  Correspondence between Ca²⁺ and calciuria, citrate level and pH of urine in pediatric urolithiasis.

Authors:  Tadeusz Porowski; Jan K Kirejczyk; Jerzy Konstantynowicz; Anna Kazberuk; Grzegorz Plonski; Anna Wasilewska; Norbert Laube
Journal:  Pediatr Nephrol       Date:  2013-02-03       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.